Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer.
Pancreatic cancer is the second most frequent gastrointestinal malignancy and carries a dismal prognosis. The current standard of care includes resection, if possible, as well as systemic chemoradiation therapy. Endoscopic ultrasound (EUS) is an established technique for the diagnosis and staging of pancreatic adenocarcinoma. Interventional EUS via fine needle injection (FNI) for the treatment of pancreatic cancer is a rapidly expanding field. The present article reviews the up-to-date developments in EUS FNI for intratumoural pancreatic cancer therapy, including antitumoural agents, immunotherapy, ablative techniques and new delivery systems. The therapeutic modalities discussed are currently under development and will hopefully reach clinical practice if benefit is demonstrated through clinical trials. EUS FNI may be an exciting new technique for the delivery of desperately needed novel therapies for pancreatic cancer.
Yan
Brian M
BM
Division of Gastroenterology, University of Calgary, Calgary, Canada. bmyan@ucalgary.ca
Van Dam
Jacques
J
D000256:Adenoviridae; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001918:Brachytherapy; D017115:Catheter Ablation; D002986:Clinical Trials as Topic; D019160:Endosonography; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D015552:Injections, Intralesional; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*; D010778:Photochemotherapy; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional; D014765:Viral Vaccines
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D014765:Viral Vaccines; C464532:dl1520